文献速递生殖医学

为预防复发性流产而接受抗凝治疗的先兆流产患者的结局

Outcomes of threatened abortions after anticoagulation treatment to prevent recurrent pregnancy loss.
PubMed 文献 · Reprod Biomed Online · 2017-07-03

回顾性分析2007至2016年间因复发性流产(RPL)使用低分子量肝素(LMWH)期间发生先兆流产的114例患者,总体活产率为58.8%(67/114)。停用LMWH者活产率87.2%(41/47)高于继续用药者38.8%(26/67),P<0.0001,停用LMWH是活产的唯一显著预测因素。抗磷脂综合征(APLS)患者继续用药者9例中8例活产。

要点

  • RPL患者使用LMWH期间发生先兆流产,停用LMWH者活产率87.2%(41/47),继续用药者38.8%(26/67),P<0.0001。
  • 多因素分析中停用LMWH是活产结局的唯一显著预测因素(P<0.0001)。
  • APLS患者继续LMWH治疗者9例中8例活产,作者主张该亚组不撤药。

核心结论

  • 对于使用LMWH预防RPL期间发生先兆流产的妇女,继续LMWH与活产率呈负相关,作者支持在此情况下停用LMWH。
  • 在APLS患者中,继续LMWH可获得相对较高的活产率,作者主张该亚组患者不撤药。

研究设计与样本

  • 回顾性分析2007年至2016年间因RPL使用LMWH期间发生先兆流产的妇女资料,共114例。
  • 所有患者均接受LMWH依诺肝素40 mg。
  • 38例(33.3%)存在易栓症,其中11例(9.6%)为抗磷脂综合征(APLS)。

主要发现

  • 总体活产率为58.8%(67/114)。
  • 停用LMWH者活产率为87.2%(41/47),继续LMWH者活产率为38.8%(26/67),P<0.0001。
  • APLS患者中,继续LMWH的9例中8例活产。
  • 多因素分析中,停用LMWH是活产结局的唯一显著预测因素(P<0.0001)。
  • 易栓症、绒毛膜下血肿及出血严重程度与活产结局无显著关联。

临床怎么用

  • 作者支持对使用LMWH预防RPL期间发生先兆流产的妇女停用LMWH。
  • 作者主张APLS患者发生先兆流产时不撤用LMWH。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We aimed to determine the outcome of threatened abortion in women treated with low-molecular weight heparin (LMWH) for recurrent pregnancy loss (RPL). Data of women with RPL who experienced threatened abortion while taking LMWH between 2007 and 2016 were retrospectively reviewed. All patients received the LMWH, enoxaparin (40 mg). Thrombophilia was present in 38 (33.3%) women, including 11 (9.6%) with antiphospholipid syndrome (APLS). The overall live birth rate was 58.8% (67/114). Live birth rates were 87.2% (41/47 patients) and 38.8% (26/67 patients) among those who discontinued versus those who continued LMWH treatment, respectively (P < 0.0001). Among APLS patients, live births resulted in eight of the nine women who continued LMWH. In multivariate analysis, discontinuation of LMWH was the only significant predictor of live birth outcome (P < 0.0001). Thrombophilia, presence of subchorionic haematoma, and severity of bleeding were not found to be associated with live birth outcomes. For women with threatened abortions, continuation of LMWH indicated to prevent RPL was negatively associated with live birth rates. Therefore, we support its discontinuation in this setting. Among women with APLS, LMWH continuation resulted in a relatively high live birth rate; we advocate against its withdrawal in this subset of patients.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Rottenstreich A, Amsalem H, Kleinstern G, et al. Outcomes of threatened abortions after anticoagulation treatment to prevent recurrent pregnancy loss. Reprod Biomed Online. 2017. PMID: 28756129. doi:10.1016/j.rbmo.2017.06.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。